Psychopharmacology

, Volume 180, Issue 4, pp 612–623

Abnormal frontal activations related to decision-making in current and former amphetamine and opiate dependent individuals

  • K. D. Ersche
  • P. C. Fletcher
  • S. J. G. Lewis
  • L. Clark
  • G. Stocks-Gee
  • M. London
  • J. B. Deakin
  • T. W. Robbins
  • B. J. Sahakian
Original Investigation

Abstract

Rationale

There is converging evidence for impairments in decision-making in chronic substance users. In the light of findings that substance abuse is associated with disruptions of the functioning of the striato–thalamo–orbitofrontal circuits, it has been suggested that decision-making impairments are linked to frontal lobe dysfunction. We sought to investigate this possibility using functional neuroimaging.

Methods

Decision-making was investigated using the Cambridge Risk Task during H215O PET scans. A specific feature of the Risk Task is the decisional conflict between an unlikely high reward option and a likely low reward option. Four groups, each consisting of 15 participants, were compared: chronic amphetamine users, chronic opiate users, ex-drug users who had been long-term amphetamine/opiate users but are abstinent from all drugs of abuse for at least 1 year and healthy matched controls without a drug-taking history.

Results

During decision-making, control participants showed relatively greater activation in the right dorsolateral prefrontal cortex, whereas participants engaged in current or previous drug use showed relatively greater activation in the left orbitofrontal cortex.

Conclusion

Our results indicate a disturbance in the mediation by the prefrontal cortex of a risky decision-making task associated with amphetamine and opiate abuse. Moreover, this disturbance was observed in a group of former drug users who had been abstinent for at least 1 year.

Keywords

Amphetamine Opiates Abstinence Substance abuse Decision making Risk taking Orbitofrontal Dorsolateral Prefrontal Neuroimaging 

References

  1. Aitken C, Kerger M, Crofts N (2000) Drivers who use illicit drugs: behaviour and perceived risks. Drugs Educ Prev Policy 7:39–50CrossRefGoogle Scholar
  2. Albery IP, Strang J, Gossop M, Griffiths P (2000) Illicit drugs and driving: prevalence, beliefs and accident involvement among a cohort of current out-of-treatment drug users. Drug Alcohol Depend 58:197–204CrossRefPubMedGoogle Scholar
  3. Alleyne BC, Stuart P, Copes R (1991) Alcohol and other drug-use in occupational fatalities. J Occup Environ Med 33:496–500Google Scholar
  4. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders—4th edn. American Psychiatric Association, Washington, DCGoogle Scholar
  5. Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC (2004) Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev 111:33–51CrossRefPubMedGoogle Scholar
  6. Bechara A, Damasio H, Damasio AR (2000) Emotion, decision making and the orbitofrontal cortex. Cereb Cortex 10:295–307CrossRefPubMedGoogle Scholar
  7. Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, Nathan PE (2001) Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia 39:376–389CrossRefPubMedGoogle Scholar
  8. Bechara A, Dolan S, Hindes A (2002) Decision-making and addiction (part II): myopia for the future or hypersensitivity to reward? Neuropsychologia 40:1690–1705CrossRefPubMedGoogle Scholar
  9. Beck AT, Steer RA, Brown GK (1996) Manual for Beck Depression Inventory-II. Psychological Corporation, San Antonio, TXGoogle Scholar
  10. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate—a practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Methodol 57:289–300Google Scholar
  11. Bolla KI, Eldreth DA, London ED, Kiehl KA, Mouratidis M, Contoreggi C, Matochik JA, Kurian V, Cadet JL, Kimes AS, Funderburk FR, Ernst M (2003) Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage 19:1085–1094CrossRefPubMedGoogle Scholar
  12. British Medical Association (1995) Alcohol: guidelines on sensible drinking. BMA, LondonGoogle Scholar
  13. Clark L, Robbins TW (2002) Decision-making deficits in drug addiction. Trends Cogn Sci 6:361–363CrossRefPubMedGoogle Scholar
  14. Clark L, Cools R, Robbins TW (2004) The neuropsychology of ventral prefrontal cortex: decision-making and reversal learning. Brain Cogn 55:41–53CrossRefPubMedGoogle Scholar
  15. Damasio AR (1994) Descartes’ error: emotion, reason, and the human brain. Grosset/Pullman, New YorkGoogle Scholar
  16. Darke S, Kelly E, Ross J (2004) Drug driving among injecting drug users in Sydney, Australia: prevalence, risk factors and risk perceptions. Addiction 99:175–185CrossRefPubMedGoogle Scholar
  17. D’Esposito M, Aguirre GK, Zarahn E, Ballard D, Shin RK, Lease J (1998) Functional MRI studies of spatial and nonspatial working memory. Cogn Brain Res 7:1–13CrossRefGoogle Scholar
  18. Elliott R, Dolan RJ, Frith CD (2000) Dissociable functions in the medial and lateral orbitofrontal cortex: evidence from human neuroimaging studies. Cereb Cortex 10:308–317CrossRefPubMedGoogle Scholar
  19. EMCDDA (1999) Literature review of the relation between drug use, impaired driving and traffic accidents. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), LisbonGoogle Scholar
  20. Ernst M, Bolla K, Mouratidis M, Contoreggi C, Matochik JA, Kurian V, Cadet JL, Kimes AS, London ED (2002) Decision-making in a risk-taking task: a PET study. Neuropsychopharmacology 26:682–691CrossRefPubMedGoogle Scholar
  21. Fellows LK, Farah MJ (2005) Different underlying impairments in decision-making following ventromedial and dorsolateral frontal lobe damage in humans. Cereb Cortex 15:58–63CrossRefPubMedGoogle Scholar
  22. Fletcher PC (2004) Functional neuroimaging of psychiatric disorders: exploring hidden behaviour. Psychol Med 34:577–581CrossRefPubMedGoogle Scholar
  23. Fletcher PC, Henson RNA (2001) Frontal lobes and human memory—insights from functional neuroimaging. Brain 124:849–881CrossRefPubMedGoogle Scholar
  24. Garavan H, Kelley D, Rosen A, Rao SM, Stein EA (2000) Practice-related functional activation changes in a working memory task. Microsc Res Tech 51:54–63CrossRefPubMedGoogle Scholar
  25. Genovese CR, Lazar NA, Nichols T (2002) Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 15:870–878CrossRefPubMedGoogle Scholar
  26. Goldstein RZ, Volkow ND, Wang GJ, Fowler JS, Rajaram S (2001) Addiction changes orbitofrontal gyrus function: involvement in response inhibition. NeuroReport 12:2595–2599CrossRefPubMedGoogle Scholar
  27. Goldstein RZ, Volkow ND, Chang L, Wang GJ, Fowler JS, Depue RA, Gur RC (2002) The orbitofrontal cortex in methamphetamine addiction: involvement in fear. NeuroReport 13:2253–2257CrossRefPubMedGoogle Scholar
  28. Grant S, Contoreggi C, London ED (2000) Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia 38:1180–1187CrossRefPubMedGoogle Scholar
  29. Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, Busch MP, Tobler LH, Phelps B, Moss AR (2002) Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis 186:1558–1564CrossRefPubMedGoogle Scholar
  30. Hester R, Garavan H (2004) Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J Neurosci 24:11017–11022CrossRefPubMedGoogle Scholar
  31. Howell DC (1997) Statistical methods for psychology, 4th edn. Duxbury Press, LondonGoogle Scholar
  32. Jentsch JD, Taylor JR (1999) Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology 146:373–390PubMedCrossRefGoogle Scholar
  33. Kelly AMC, Hester R, Murphy K, Javitt DC, Foxe JJ, Garavan H (2004) Prefrontal-subcortical dissociations underlying inhibitory control revealed by event-related fMRI. Eur J Neurosci 19:3105–3112CrossRefPubMedGoogle Scholar
  34. Krawczyk DC (2002) Contributions of the prefrontal cortex to the neural basis of human decision making. Neurosci Biobehav Rev 26:631–664CrossRefPubMedGoogle Scholar
  35. Lingford-Hughes A, Nutt DJ (2003) Neurobiology of addiction and implications for treatment. Br J Psychiatry 182:97–100CrossRefPubMedGoogle Scholar
  36. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003) An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19:1233–1239CrossRefPubMedGoogle Scholar
  37. Matochik JA, London ED, Eldreth DA, Cadet JL, Bolla KI (2003) Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study. Neuroimage 19:1095–1102CrossRefPubMedGoogle Scholar
  38. Nelson HE (1982) National adult reading test manual. NFER-Nelson, Windsor, UKGoogle Scholar
  39. Nestler EJ (2002) From neurobiology to treatment: progress against addiction. Nat Neurosci 5:1076–1079CrossRefPubMedGoogle Scholar
  40. O’Doherty J, Critchley H, Deichmann R, Dolan RJ (2003) Dissociating valence of outcome from behavioral control in human orbital and ventral prefrontal cortices. J Neurosci 23:7931–7939PubMedGoogle Scholar
  41. Ornstein TJ, Iddon JL, Baldacchino AM, Sahakian BJ, London M, Everitt BJ, Robbins TW (2000) Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology 23:113–126CrossRefPubMedGoogle Scholar
  42. Patton JH, Stanford MS, Barratt ES (1995) Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol 51:768–774PubMedCrossRefGoogle Scholar
  43. Paulus MP, Hozack NE, Zauscher BE, Frank L, Brown GG, Braff DL, Schuckit MA (2002) Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology 26:53–63CrossRefPubMedGoogle Scholar
  44. Paulus MP, Hozack N, Frank L, Brown GG, Schuckit MA (2003) Decision making by methamphetamine-dependent subjects is associated with error-rate-independent decrease in prefrontal and parietal activation. Biol Psychiatry 53:65–74CrossRefPubMedGoogle Scholar
  45. Pollack ES, Franklin GM, Fulton-Kehoe D, Chowdhury R (1998) Risk of job-related injury among construction laborers with a diagnosis of substance abuse. J Occup Environ Med 40:573–577CrossRefPubMedGoogle Scholar
  46. Raichle ME, Martin WRW, Herscovitch P, Mintun MA, Markham J (1983) Brain blood-flow measured with intravenous (H2O)-O-15. 2. Implementation and validation. J Nucl Med 24:790–798PubMedGoogle Scholar
  47. Robbins TW, Everitt BJ (1999) Drug addiction: bad habits add up. Nature 398:567–570CrossRefPubMedGoogle Scholar
  48. Robinson TE, Berridge KC (2001) Incentive-sensitization and addiction. Addiction 96:103–114CrossRefPubMedGoogle Scholar
  49. Robinson TE, Kolb B (1997) Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 17:8491–8497PubMedGoogle Scholar
  50. Robinson TE, Kolb B (1999) Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci 11:1598–1604CrossRefPubMedGoogle Scholar
  51. Rogers RD, Robbins TW (2001) Investigating the neurocognitive deficits associated with chronic drug misuse. Curr Opin Neurobiol 11:250–257CrossRefPubMedGoogle Scholar
  52. Rogers RD, Everitt BJ, Baldacchino A, Blackshaw AJ, Swainson R, Wynne K, Baker NB, Hunter J, Carthy T, Booker E, London M, Deakin JFW, Sahakian BJ, Robbins TW (1999a) Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology 20:322–339CrossRefPubMedGoogle Scholar
  53. Rogers RD, Owen AM, Middleton HC, Williams EJ, Pickard JD, Sahakian BJ, Robbins TW (1999b) Choosing between small, likely rewards and large, unlikely rewards activates inferior and orbital prefrontal cortex. J Neurosci 19:9029–9038PubMedGoogle Scholar
  54. Rogers RD, Ramnani N, Mackay C, Wilson JL, Jezzard P, Carter CS, Smith SM (2004) Distinct portions of anterior cingulate cortex and medial prefrontal cortex are activated by reward processing in separable phases of decision-making cognition. Biol Psychiatry 55:594–602CrossRefPubMedGoogle Scholar
  55. Rubinsztein JS, Fletcher PC, Rogers RD, Ho LW, Aigbirhio FI, Paykel ES, Robbins TW, Sahakian BJ (2001) Decision-making in mania: a PET study. Brain 124:2550–2563CrossRefPubMedGoogle Scholar
  56. Segarra P, Molto J, Torrubia R (2000) Passive avoidance learning in extraverted females. Pers Individ Differ 29:239–254CrossRefGoogle Scholar
  57. Sklair-Tavron L, Shi WX, Lane SB, Harris HW, Bunney BS, Nestler EJ (1996) Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc Natl Acad Sci U S A 93:11202–11207CrossRefPubMedGoogle Scholar
  58. Smith EE, Jonides J (1999) Storage and executive processes in the frontal lobes. Science 283:1657–1661CrossRefPubMedGoogle Scholar
  59. Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, Dewey SL, Wolf AP (1993) Decreased dopamine-D(2) receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14:169–177CrossRefPubMedGoogle Scholar
  60. Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Ding YS, Pappas N, Shea C, Piscani K (1996) Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 20:1594–1598PubMedGoogle Scholar
  61. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Gifford A, Hitzemann R, Ding YS, Pappas N (1999a) Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D-2 receptor levels. Am J Psychiatry 156:1440–1443PubMedGoogle Scholar
  62. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Wong C, Hitzemann R, Pappas NR (1999b) Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D-2 receptors. J Pharmacol Exp Ther 291:409–415PubMedGoogle Scholar
  63. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N (2001) Low level of brain dopamine D-2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158:2015–2021CrossRefPubMedGoogle Scholar
  64. Wang GJ, Volkow ND, Fowler JS, Logan J, Abumrad NN, Hitzemann RJ, Pappas NS, Pascani K (1997) Dopamine D-2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology 16:174–182CrossRefPubMedGoogle Scholar
  65. Wang GJ, Volkow ND, Chang L, Miller E, Sedler M, Hitzemann R, Zhu W, Logan J, Ma Y, Fowler JS (2004) Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am J Psychiatry 161:242–248CrossRefPubMedGoogle Scholar
  66. Wilkinson D, Halligan P (2004) Opinion—the relevance of behavioural measures for functional-imaging studies of cognition. Nat Rev Neurosci 5:67–73CrossRefPubMedGoogle Scholar
  67. Zald DH, Pardo JV (1997) Emotion, olfaction, and the human amygdala: amygdala activation during aversive olfactory stimulation. Proc Natl Acad Sci U S A 94:4119–4124CrossRefPubMedGoogle Scholar
  68. Zhang JX, Leung HC, Johnson MK (2003) Frontal activations associated with accessing and evaluating information in working memory: an fMRI study. Neuroimage 20:1531–1539CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • K. D. Ersche
    • 1
  • P. C. Fletcher
    • 1
    • 2
  • S. J. G. Lewis
    • 2
  • L. Clark
    • 2
    • 3
  • G. Stocks-Gee
    • 4
  • M. London
    • 5
  • J. B. Deakin
    • 1
  • T. W. Robbins
    • 2
    • 3
  • B. J. Sahakian
    • 1
    • 2
  1. 1.Department of Psychiatry, School of Clinical Medicine, Addenbrooke’s HospitalUniversity of CambridgeCambridgeUK
  2. 2.MRC Centre for Behavioural and Clinical NeuroscienceUniversity of CambridgeCambridgeUK
  3. 3.Department of Experimental PsychologyUniversity of CambridgeCambridgeUK
  4. 4.Wolfson Brain Imaging Centre, Addenbrooke’s HospitalUniversity of CambridgeCambridgeUK
  5. 5.Brookfields HospitalCambridge Drug & Alcohol ServiceCambridgeUK

Personalised recommendations